Analgesics - Gambia | Statista Market Forecast

In Gambia, the revenue in the Analgesics market is projected to reach US$771.10k in 2024.
It is anticipated that the market will experience an annual growth rate of 10.19% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue with US$7.24bn in 2024.
In terms of per capita figures, the revenue generated per person in Gambia amounts to US$0.27 in 2024.
The demand for analgesics in Gambia is rising due to the increasing prevalence of chronic pain conditions among the elderly population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Gambia has been experiencing significant growth in recent years.

Customer preferences: Customers in Gambia have shown a strong preference for analgesics that provide quick and effective pain relief. They are particularly interested in products that are easy to use and have minimal side effects. Additionally, customers in Gambia value affordability and are more likely to purchase analgesics that are reasonably priced.

Trends in the market: One of the key trends in the Analgesics market in Gambia is the increasing demand for over-the-counter (OTC) analgesics. This can be attributed to several factors, including the rising awareness about self-medication and the convenience of purchasing OTC products without a prescription. As a result, pharmaceutical companies have been focusing on expanding their OTC product offerings in order to cater to this growing demand.Another trend in the market is the rising popularity of natural and herbal analgesics. Customers in Gambia are increasingly seeking out products that are derived from natural sources and have fewer synthetic ingredients. This trend is driven by a growing awareness of the potential side effects of conventional analgesics and a desire for more holistic healthcare options.

Local special circumstances: Gambia is a small country located in West Africa with a population that is predominantly rural. This has implications for the Analgesics market, as access to healthcare facilities and pharmacies may be limited in certain areas. As a result, customers in these areas rely heavily on local markets and informal vendors for their healthcare needs. This presents both challenges and opportunities for pharmaceutical companies operating in the Analgesics market in Gambia.

Underlying macroeconomic factors: The growing middle class in Gambia has contributed to the increasing demand for analgesics. As disposable incomes rise, more people are able to afford healthcare products, including analgesics. Additionally, the government of Gambia has been investing in healthcare infrastructure and services, which has further fueled the growth of the Analgesics market.In conclusion, the Analgesics market in Gambia is experiencing growth due to customer preferences for quick and effective pain relief, the increasing demand for OTC products, and the rising popularity of natural and herbal analgesics. The local special circumstances, such as limited access to healthcare facilities in rural areas, also play a role in shaping the market. Overall, the market is driven by underlying macroeconomic factors, including the growing middle class and government investments in healthcare.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.